Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags

Cancer Biology and Therapy

Volumn 3, Issue 11, 2004, Pages 1081-1089

  Cao, Dengfeng ^a   Hustinx, Steven R ^a,c   Sui, Guoping ^a   Bala, P ^d   Sato, Norihiro ^a   Martin, Sean ^a   Maitra, Anirban ^a,b   Murphy, Kathleen M ^a   Cameron, John L ^a   Yeo, Charles J ^a   Kern, Scott E ^a   Goggins, Michael ^a   Pandey, Akhilesh ^b   Hruban, Ralph H ^a,e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Institute of Bioinformatics   (India)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Affymetrix; Gene expression; Microarray; Pancreatic cancer

Indexed keywords

BETA1 INTEGRIN; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; DNA FRAGMENT; EPHRIN A5; ETS DOMAIN PROTEIN; INHIBIN A; INITIATION FACTOR 5A; INITIATION FACTOR 5A2; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXQ1; UNCLASSIFIED DRUG; MESSENGER RNA; TUMOR MARKER;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER SURGERY; CLINICAL ARTICLE; COLON; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; DUODENUM MUCOSA; EXPRESSED SEQUENCE TAG; GENE; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SEQUENCE ANALYSIS; SPECIES COMPARISON; TISSUE MICROARRAY; ADENOCARCINOMA; BIOLOGY; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; COMPUTATIONAL BIOLOGY; DNA, COMPLEMENTARY; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 22144450017     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.11.1175     Document Type: Article

References (47)

1. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, et al. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002; 21:4587-94.
2. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, et al. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002; 62:2890-6.
3. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002; 160:1239-49.
4. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63:2649-57.
5. Ryu B, Jones JB, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH, et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res 2002; 62:819-26.
6. Tan ZJ, Hu XG, Cao GS, Tang Y. Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray. World J Gastroenterol 2003; 9:818-23.
7. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003; 63:8614-22.
8. Argani P, Iacobuzio-Donahue CA, Ryu B, Rosty C, Goggins M, Wilentz RE, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7:3862-8.
9. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SD, Leach SD, et al. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001; 61:4320-4.
10. McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, van Heek NT, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: Mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003; 11:238-43.
11. Koopmann J, Fedarko NS, Jain A, Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2004; 13:487-91.
12. Hassan R, Viner JL, Wang QC, Margulies I, Kreitman RJ, Pastan I. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J Immunother 2000; 23:473-9.
13. American Cancer Society Cancer Facts & Figures 2003. 2003; 1-48.
14. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-410.
15. Schultz J, Milpetz F, Bork P, Ponting CP. SMART, a simple modular architecture research tool: Identification of signaling domains. Proc Natl Acad Sci USA 1998; 95:5857-64.
16. Maitra A, Iacobuzio-Donahue C, Rahman A, Sohn TA, Argani P, Meyer R, et al. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: Sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002; 118:52-59.
17. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996; 148:1763-70.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25:402-8.
19. Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol 1997; 7:270-6.
20. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271:350-3.
21. Goggins M, Shekher M, Kenan T, Yeo CJ, Hruban RH, Kern SE. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 1998; 58:5329-32.
22. Kleeff J, Ishiwata T, Friess H, Buchler MW, Korc M. Concomitant over-expression of activin/inhibin β subunits and their receptors in human pancreatic cancer. Int J Cancer 1998; 77:860-8.
23. Su GH, Bansal R, Murphy KM, Montgomery E, Yeo CJ, Hruban RH, et al. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma. Proc Natl Acad Sci USA 2001; 98:3254-7.
24. Poulaki V, Mitsiades N, Kruse FE, Radetzky S, Iliaki E, Kirchhof B, et al. Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression. Am J Pathol 2004; 164:1293-302.
25. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003; 22:319-29.
26. Wang H, Fu W, Im JH, Zhou Z, Santoro SA, Iyer V, et al. Tumor cell α3ß1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 2004; 164:935-41.
27. Berry MG, Goode AW, Puddefoot JR, Vinson GP, Carpenter R. Integrin β1-mediated invasion of human breast cancer cells: An ex vivo assay for invasiveness. Breast Cancer 2003; 10:214-9.
28. Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Hisatomi A, et al. Mechanism of β 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2. Hepatology 2003; 38:305-13.
29. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW. A biochemical characterization of the binding of osteopontin to integrins α v β 1 and α v β 5. J Biol Chem 1995; 270:26232-8.
30. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004; 10:184-90.
31. Kruzynska-Frejtag A, Wang J, Maeda M, Rogers R, Krug E, Hoffman S, et al. Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn 2004; 229:857-68.
32. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β. J Bone Miner Res 1999; 14:1239-49.
33. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for α(V)β(3) and α(V)β(5) integrins and promotes cell motility. Cancer Res 2002; 62:5358-64.
34. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang TL, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004; 24:3992-4003.
35. Maira SM, Wurtz JM, Wasylyk B. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J 1996; 15:5849-65.
36. Nakade K, Zheng H, Ganguli G, Buchwalter G, Gross C, Wasylyk B. The tumor suppressor p53 inhibits net, an effector of Ras/extracellular signal-regulated kinase signaling. Mol Cell Biol 2004; 24:1132-42.
37. Giovane A, Pintzas A, Maira SM, Sobieszczuk P, Wasylyk B. Net, a new ets transcription factor that is activated by Ras. Genes Dev 1994; 8:1502-13.
38. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143:545-54.
39. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994; 54:3025-33.
40. Lioubinski O, Muller M, Wegner M, Sander M. Expression of Sox transcription factors in the developing mouse pancreas. Dev Dyn 2003; 227:402-8.
41. Friedman RS, Bangur CS, Zasloff EJ, Fan L, Wang T, Watanabe Y, et al. Molecular and immunological evaluation of the transcription factor SOX-4 as a lung tumor vaccine antigen. J Immunol 2004; 172:3319-27.
42. Frierson Jr HF, El Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002; 161:1315-23.
43. Lee CJ, Appleby VJ, Orme AT, Chan WI, Scotting PJ. Differential expression of SOX4 and SOX11 in medulloblastoma. J Neurooncol 2002; 57:201-14.
44. Xia W, Unger P, Miller L, Nelson J, Gelman IH. The Src-sup pressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 2001; 61:5644-51.
45. Jenkins ZA, Haag PG, Johansson HE. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 2001; 71:101-9.
46. Clement PM, Henderson CA, Jenkins ZA, Smit-McBride Z, Wolff EC, Hershey JW, et al. Identification and characterization of eukaryotic initiation factor 5A-2. Eur J Biochem 2003; 270:4254-63.
47. Bieller A, Pasche B, Frank S, Glaser B, Kunz J, Witt K, et al. Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol 2001; 20:555-61.